Comparison between zofenopril and ramipril in combination with ASA [aspirin] on the extent of cardiovascular risk in patients with systolic left ventricular dysfunction after acute myocardial infarction

Trial Profile

Comparison between zofenopril and ramipril in combination with ASA [aspirin] on the extent of cardiovascular risk in patients with systolic left ventricular dysfunction after acute myocardial infarction

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Zofenopril (Primary) ; Aspirin; Ramipril
  • Indications Cardiovascular disorders; Heart failure; Left ventricular dysfunction; Myocardial infarction
  • Focus Registrational; Therapeutic Use
  • Acronyms SMILE-4; SMILE-IV
  • Sponsors Menarini
  • Most Recent Events

    • 15 Jun 2015 Results of 5 year follow up presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 22 May 2013 Results presented at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
    • 15 Jun 2012 Results published in Clinical Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top